17beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells

Reproductive Biology and Endocrinology

Volumn 3, Issue , 2005, Pages

  Lesmeister, Margaret J ^a   Jorgenson, Rebecca L ^a   Young, Steven L ^b   Misfeldt, Michael L ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DOUBLE STRANDED DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MIFEPRISTONE; POLYINOSINIC POLYCYTIDYLIC ACID; PROGESTERONE; STEROID RECEPTOR; TOLL LIKE RECEPTOR 3; DRUG DERIVATIVE; ESTROGEN RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; POLY D(I C); POLY D(I-C); POLYDEOXYRIBONUCLEOTIDE; PROGESTERONE RECEPTOR; TLR3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHEMICAL PROCEDURES; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; TUMOR CELL LINE;

ANIMALIA;

CELL LINE; CELL LINE, TUMOR; CHEMOKINES; CYTOKINES; ENDOMETRIUM; EPITHELIAL CELLS; ESTRADIOL; FEMALE; HUMANS; MIFEPRISTONE; POLY I-C; POLYDEOXYRIBONUCLEOTIDES; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TOLL-LIKE RECEPTOR 3;

EID: 30544443971     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-3-74     Document Type: Article

References (51)

1. Robertson S, Hudson S: Cytokines: pivotal regulators of endometrial immunobiology. In In The Endometrium. Edited by SR Glasser, JD Aplin, LC Giudice, S Tabibzadeh. New York: Taylor and Frances; 2002:416-433.
2. Saito S: Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 2001, 52: 15-33.
3. Kelly RW, King AE, Critchley HO: Cytokine control in human endometrium. Reproduction 2001, 121:3-19.
4. Kayisli UA, Mahutte NG, Arici A: Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002, 47: 213-221.
5. von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S: Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod 2000, 6: 627-634.
6. Arici A: Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis. Ann N Y Acad Sci 2002, 955: 101-109.
7. Harada T, Yoshioka H, Yoshida S, Iwabe T, Onohara Y, Tanikawa M, Terakawa N: Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997, 176:593-597.
8. Ryan IP, Tseng JF, Schriock ED, Khorram O, Landers DV, Taylor RN: Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995, 63: 929-932.
9. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL: Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996, 2:40-45.
10. Gazvani MR, Christmas S, Quenby S, Kirwan J, Johnson PM, Kingsland CR: Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum Reprod 1998, 13: 1957-1961.
11. DeMayo FJ, Zhao B, Takamoto N, Tsai SY: Mechanisms of action of estrogen and progesterone. Ann N Y Acad Sci 2002, 955: 48-59.
12. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC: 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994, 93: 944-950.
13. Tabibzadeh SS, Santhanam U, Sehgal PB, May LT: Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol 1989, 142: 3134-3139.
14. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC: 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992, 89: 883-891.
15. Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV, Taylor RN: Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996, 81: 1118-1122.
16. von Wolff M, Stieger S, Lumpp K, Bucking J, Strowitzki T, Thaler CJ: Endometrial interleukin-6 in vitro is not regulated directly by female steroid hormones, but by pro-inflammatory cytokines and hypoxia. Mol Hum Reprod 2002, 8: 1096-1102.
17. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV: Production of interleukin-6 in human osteoblasts and human bone marrow stromal. cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology 1995, 136: 4056-4067.
18. Armant MA, Fenton MJ: Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 2002, 3: REVIEWS3011.
19. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21: 335-376.
20. Janeway CA, Jr., Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002, 20: 197-216.
21. Beutler B: Innate immunity: an overview. Mol Immunol 2004, 40: 845-859.
22. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1: 135-145.
23. Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2: 675-680.
24. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2: 947-950.
25. Young SL, Lyddon TD, Jorgenson RL, Misfeldt ML: Expression of Toll-like receptors in human endometrial epithelial cells and cell lines. Am J Reprod Immunol 2004, 52: 67-73.
26. Jorgenson RL, Young SL, Lesmeister MJ, Lyddon TD, Misfeldt ML: Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA. Hum Immunol 2005, 66: 469-482.
27. Schaefer TM, Fahey JV, Wright JA, Wira CR: Innate Immunity in the Human Female Reproductive Tract: Antiviral Response of Uterine Epithelial Cells to the TLR3 Agonist Poly(I:C). J Immunol 2005, 174: 992-1002.
28. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR: TOR-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004, 112: 428-436.
29. Prange-Kiel J, Rune GM, Zwirner M, Wallwiener D, Kiesel L: Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells. Exp Clin Endocrinol Diabetes 2001, 109: 231-237.
30. Wei LL, Krett NL, Francis MD, Gordon DF, Wood WM, O'Malley BW, Horwitz KB: Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol Endocrinol 1988, 2:62-72.
31. Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS: Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 1988, 2: 263-271.
32. Kodama F, Greene GL, Salmon SE: Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res 1985, 45: 2720-2724.
33. Jana NR, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C, Sone H: Role of estradiol. receptor-alpha in differential expression of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. Arch Biochem Biophys 1999, 368: 31-39.
34. Richardson GS, Dickersin GR, Atkins L, MacLaughlin DT, Raam S, Merk LP, Bradley FM: KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol 1984, 17: 213-230.
35. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC: Production and actions of estrogens. N Engl J Med 2002, 346: 340-352.
36. Ray P, Ghosh SK, Zhang DH, Ray A: Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997, 409: 79-85.
37. Bramlett KS, Burris TP: Target specificity of selective estrogen receptor modulators within human endometrial cancer cells. J Steroid Biochem Mol Biol 2003, 86: 27-34.
38. Nawaz Z, Stancel GM, Hyder SM: The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription. Cancer Res 1999, 59: 372-376.
39. McClelland RA, Barrow D, Madden TA, Dutkowski CM, Pamment J, Knowlden JM, Gee JM, Nicholson RI: Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex). Endocrinology 2001, 142: 2776-2788.
40. McClelland RA, Gee JM, Francis AB, Robertson JF, Blamey RW, Wakeling AE, Nicholson RI: Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer. Eur J Cancer 1996, 32A: 413-416.
41. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990, 9: 1603-1614.
42. Tora L, Gronemeyer H, Turcotte B, Gaub MP, Chambon P: The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 1988, 333: 185-188.
43. Lessey BA: Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 2003, 68: 809-815.
44. Aronica SM, Fanti P, Kaminskaya K, Gibbs K, Raiber L, Nazareth M, Bucelli R, Mineo, M, Grzybek K, Kumin M, Poppenberg K, Schwach C, Janis K: Estrogen disrupts chemokine-mediated chemokine release from mammary cells: implications for the interplay between estrogen and IP-10 in the regulation of mammary tumor formation. Breast Cancer Res Treat 2004, 84: 235-245.
45. McDonagh S, Maidji E, Ma W, Chang HT, Fisher S, Pereira L: Viral and bacterial pathogens at the maternal-fetal interface. J Infect Dis 2004, 190: 826-834.
46. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS, Jr.: Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988, 67: 334-340.
47. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, Milgrom E Perrot-Applanat M: Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 1988, 67: 80-87.
48. Press MF, Udove JA, Greene GL: Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol 1988, 131: 112-124.
49. Somkuti SG, Yuan L, Fritz MA, Lessey BA: Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells. J Clin Endocrinol Metab 1997, 82: 2192-2197.
50. Galien R, Garcia T: Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res 1997, 25: 2424-2429.
51. Saceda M, Lippman ME, Lindsey RK, Puente M, Martin MB: Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol Endocrinol 1989, 3: 1782-1787.